13 units of tirzepatide Dosage Chart & GLP-1 Dose Calculator 125 units of tirzepatide dosing

Niacinamide Helps improve the appearance of uneven-looking skin tone

CagriSema pairs cagrilintide with semaglutide (a GLP-1-only drug)

BPC-157 CAS #: 137525-51-0 BPC-157 Molecular Formula: C62H98N16O22 BPC-157 Molecular Weight: 1419.556 g/mol TB-500 CAS #: 77591-33-4 TB-500 Molecular Formula: C212H350N56O78S TB-500 Molecular Weight: 4963.44 g/mol GHK-Cu CAS #: 89030-95-5 GHK-Cu Molecular Formula: C14H21N6O4Cu GHK-Cu Molecular Weight: 401.91 g/mol Blend Components: BPC-157 + TB-500 + GHK-Cu Purity Reference: 99% (HPLC) Total Fill: 70 mg Supplied for laboratory and analytical research only

Practical strategies include: Gastrointestinal symptom management: Eat smaller, more frequent meals rather than large portions Avoid high-fat, spicy, or heavily processed foods that may exacerbate nausea Stay well-hydrated, sipping water throughout the day rather than drinking large volumes at once Consider ginger tea for nausea, though evidence is limited and patients should discuss any remedies with their healthcare provider Take the injection at a consistent time, preferably when you can rest if nausea occurs Hydration and urinary health: Maintain adequate fluid intake (approximately 1.5-2 litres daily unless otherwise advised by your healthcare professional, particularly if you have heart, liver or kidney disease) Monitor urine colourpale yellow indicates adequate hydration Avoid excessive caffeine or alcohol, which have diuretic effects Practice good perineal hygiene to reduce urinary tract infection risk Medication optimisation: The graduated dosing schedule is designed to improve tolerability

CagriSema (the combination) was submitted for FDA approval in December 2025, but cagrilintide on its own is earlier in the process

Recent hospitalization and the reason for the same